Unique challenges faced by the clinical evaluation of dengue vaccines
- PMID: 21332260
- DOI: 10.1586/erv.10.159
Unique challenges faced by the clinical evaluation of dengue vaccines
Similar articles
-
Tropical diseases. Hunt for dengue vaccine heats up as the disease burden grows.Science. 2007 Sep 14;317(5844):1494-5. doi: 10.1126/science.317.5844.1494. Science. 2007. PMID: 17872423 No abstract available.
-
Evaluation of interferences between dengue vaccine serotypes in a monkey model.Am J Trop Med Hyg. 2009 Feb;80(2):302-11. Am J Trop Med Hyg. 2009. PMID: 19190230
-
Dengue vaccine: opportunities and challenges.IDrugs. 2008 Jan;11(1):42-5. IDrugs. 2008. PMID: 18175262 Review.
-
Prospective human trials with dengue virus vaccines and the NS1 antigen production among vaccine recipients.Hum Vaccin. 2011 Dec;7(12):1394. doi: 10.4161/hv.7.12.17958. Epub 2011 Dec 1. Hum Vaccin. 2011. PMID: 22108041 No abstract available.
-
Development of dengue DNA vaccines.Vaccine. 2011 Sep 23;29(42):7261-6. doi: 10.1016/j.vaccine.2011.07.019. Epub 2011 Jul 21. Vaccine. 2011. PMID: 21777640 Review.
Cited by
-
Pichia pastoris-expressed dengue 3 envelope-based virus-like particles elicit predominantly domain III-focused high titer neutralizing antibodies.Front Microbiol. 2015 Sep 23;6:1005. doi: 10.3389/fmicb.2015.01005. eCollection 2015. Front Microbiol. 2015. PMID: 26441930 Free PMC article.
-
Antibody-Dependent Enhancement: A Challenge for Developing a Safe Dengue Vaccine.Front Cell Infect Microbiol. 2020 Oct 22;10:572681. doi: 10.3389/fcimb.2020.572681. eCollection 2020. Front Cell Infect Microbiol. 2020. PMID: 33194810 Free PMC article. Review.
-
Virus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed antibodies.BMC Biotechnol. 2016 Jun 14;16(1):50. doi: 10.1186/s12896-016-0280-y. BMC Biotechnol. 2016. PMID: 27301568 Free PMC article.
-
Recombinant Dengue Virus 4 Envelope Glycoprotein Virus-Like Particles Derived from Pichia pastoris are Capable of Eliciting Homotypic Domain III-Directed Neutralizing Antibodies.Am J Trop Med Hyg. 2017 Jan 11;96(1):126-134. doi: 10.4269/ajtmh.16-0503. Epub 2016 Nov 7. Am J Trop Med Hyg. 2017. PMID: 27821688 Free PMC article.
-
Pichia pastoris-Expressed Bivalent Virus-Like Particulate Vaccine Induces Domain III-Focused Bivalent Neutralizing Antibodies without Antibody-Dependent Enhancement in Vivo.Front Microbiol. 2018 Jan 9;8:2644. doi: 10.3389/fmicb.2017.02644. eCollection 2017. Front Microbiol. 2018. PMID: 29367852 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical